Exelixis reported $30.57M in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US USD 10.01M 1.85M
Agios Pharmaceuticals AGIO:US USD 10.42M 2.62M
Akebia Therapeutics AKBA:US USD 19.71M 5.24M
Bayer BAYN:GR EUR 6.55B 452M
Bluebird Bio BLUE:US USD 18.62M 6.24M
Bristol Myers Squibb BMY:US USD 2.6B 287M
Cytokinetics CYTK:US USD 14.43M 351K
Eisai 4523:JP JPY 76.83B 19.28B
Eli Lilly And LLY:US USD 1.68B 23.9M
Esperion Therapeutics ESPR:US USD 18.58M 5.75M
Exelixis EXEL:US USD 30.57M 10.59M
Immunogen IMGN:US USD 20.18M 2.93M
Macrogenics MGNX:US USD 4.62M 2.01M
Merk MRK:US USD 3.37B 111M
Mirati Therapeutics MRTX:US USD 19.45M 4.82M
Moderna Inc MRNA:US USD 330M 149M
Nektar Therapeutics NKTR:US USD 5.33M 7.02M
Novartis NOVN:VX USD 4.69B 276M
Puma Biotechnology PBYI:US USD 14.93M 5.09M
Seattle Genetics SGEN:US USD 144.5M 15.63M
Takeda 4502:JP JPY 388.62B 35.74B
Ultragenyx Pharmaceutical RARE:US USD 23.53M 10.68M
Xencor XNCR:US USD 14.62M 1.13M
YTE INCY:US USD 163.17M 31.6M